DNA

Invest Smart, Grow Fast! Industries with Up to 20% Annual Growth

"Discover High-Growth Opportunities Across Leading Sectors, With BCC Research Highlighting Industries Primed for Up to 20% Annual Returns" BOSTON, Oct.…

1 year ago

Beauty-Stem Biomedical Joins ACS Relay for Life, Championing Cancer Prevention

Beauty-Stem Biomedical continues to make strides in preventive medicine, advancing the science of stem cell nutrition to prevent and combat…

1 year ago

Geneyx and Ocean Genomics Announce SVDuo™ Release, Delivering Integrated DNA and RNA Analysis to Enhance Genomic Variant Detection for Research and Clinical Genomics

WILMINGTON, Del., Oct. 30, 2024 /PRNewswire/ -- Geneyx Inc. a pioneering global company for an AI Multi-Omics analysis system, and [Pittsburgh,…

1 year ago

Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

STONY BROOK, NY / ACCESSWIRE / October 30, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"),…

1 year ago

The Neuroscience of Inclusion and Diversity: Unlocking High-Impact Team Performance

NORTHAMPTON, MA / ACCESSWIRE / October 29, 2024 / Diversity and inclusion are not only core elements of Teva's cultural…

1 year ago

DELFI Diagnostics Names Robert Guigley as Chief Commercial Officer to Expand Access to Early Cancer Screening

Industry Leader to Drive Adoption of Breakthrough Blood-Based Technology and Fragmentomics Platform for Improved Screening and Monitoring BALTIMORE and PALO…

1 year ago

Pathos AI Closes $62M Oversubscribed Series C Round of Financing to Accelerate its Platform Approach to Drug Development

CHICAGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Pathos AI, a clinical-stage biotechnology company focused on re-engineering drug development through artificial…

1 year ago

BioXcel Therapeutics to Present at ThinkEquity Conference

NEW HAVEN, Conn., Oct. 29, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence…

1 year ago

Helio Genomics and Halub Medical Co. Announce Strategic Partnership to Commercialize HelioLiver Dx in The Gulf Cooperation Council and Middle East

IRVINE, Calif., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Helio Genomics (“Helio” or “the Company”), an AI-driven biotechnology company specializing in…

1 year ago